Daily Morning Note – 23 Oct 2020


Treasury yields rose and bank shares lifted U.S. equities as lawmakers in Washington continued to haggle over a spending bill. Asian stocks looked set for a mixed start as traders readied for the final presidential debate.

Futures edged higher in Japan, and were little changed in Hong Kong and Australia. S&P 500 contracts edged up after the benchmark closed higher with financial stocks rallying almost 2%. The 10-year Treasury yield popped to 0.84%, its highest since June, amid data showing the labor market is still gradually recovering. The dollar strengthened. Intel Corp. tumbled in after-hours trading after a tepid forecast.


First Reit’s manager will be extending a further two months of rental relief – for September and October – to all its tenants in Indonesia, a sum amounting to S$18.9 million, it said in a filing on Thursday evening. This comes on top of the rental relief for the months of May and June. Covid-19 cases in Indonesia are continuing to escalate; the country recorded its highest number of monthly cases last month, and the figure was itself a 69 per cent rise from the previous month, said the manager.

Mapletree Commercial Trust (MCT) has declared a distribution per unit (DPU) of 4.17 Singapore cents for its first half ended Sept 30, down 9.9 per cent from a year ago, said the real estate investment trust’s manager on Thursday after market close. Unitholders will receive the distribution on Nov 27. Distributable income ticked up 3.2 per cent to S$138.42 million, as S$15 million was released to unitholders in the first half. This comes as MCT had earlier made capital-allowance claims and retained capital distribution to conserve liquidity in view of the uncertain Covid-19 pandemic in the fourth quarter of FY 19/20.

Singtel‘s information, communications and technology (ICT) arm NCS has acquired regional digital services consultancy 2359 Media for an undisclosed sum. 2359 Media will become part of NCS’s NEXT digital arm. 2359 Media was founded in 2009 and specialises in leveraging cloud-based technologies to develop custom-built mobile apps, platforms and websites. Its clients come from sectors such as financial services, media, healthcare and retail.

Frasers Centrepoint Trust’s (FCT) preferential offering to raise about S$759.7 million in gross proceeds has been fully subscribed, the manager said in a bourse filing late on Wednesday. Valid acceptances and excess applications stood at about 460.4 million, 1.4 times the total number of preferential offering units available.

Keppel Corp’s wholly-owned subsidiary Lipalton has completed its investment into Kapstone Constructions, and now holds 49 per cent of the latter’s total voting rights. Kapstone is Lipalton’s joint venture (JV) with Indian developer Rustomjee Group, to develop the 51.4 hectare Urbania integrated township in the Thane district of Mumbai.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR


U.S. Elections – Sector Impact (Healthcare)

Analyst: Yeap Jun Rong

– Both Biden and Trump aim to lower drug prices to make healthcare more affordable, but Biden is expected to have a greater chance of success.

– We believe future healthcare policies are intertwined closely with the composition of the new Congress. A divided Congress may end up with little or no structural change and would be seen as largely positive for the healthcare sector.

– If a Blue Wave occurs, Biden’s ambition to remake the healthcare system may be more likely to pass. However, we believe that the near-term focus will still be on Covid-19 and any regulation or major changes may be put on hold until the worst of the crisis is over.

– We examine the impact on different healthcare industries under a Biden or Trump win. Below is a list of sector ETFs which investors may look out for.

>> Read more research reports

HK Reports – Read up on our Hong Kong reports here


Webinar Of The Week

Market Outlook: Singapore REITS Monthly, US Election (Energy & Financials Sector Update), SG Weekly

Date: 19 October 2020

For more on Market Outlook

Updates summarised in 3 minutes

Phillip Research in 3 minutes: #26 – iX Biopharma Ltd; Initiation

For more videos on Phillip in 3 Mins

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com